| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A phase II trial of docetaxel and vinorelbine in patients with hormone-refractory prostate cancer
|
Goodin, Susan
|
|
2005
|
56 |
2 |
p. 199-204
|
article
|
| 2 |
A phase I study of doxifluridine combined with weekly paclitaxel for metastatic gastric cancer
|
Moriwaki, Toshikazu
|
|
2005
|
56 |
2 |
p. 138-144
|
article
|
| 3 |
Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models
|
Smith, Victoria
|
|
2005
|
56 |
2 |
p. 126-137
|
article
|
| 4 |
Cytoprotective effects of amifostine and cysteamine on cultured normal and tumor cells treated with paclitaxel in terms of mitotic index and 3H-thymidine labeling index
|
Özcan Arican, Gül
|
|
2005
|
56 |
2 |
p. 221-229
|
article
|
| 5 |
HERG K+ channel expression-related chemosensitivity in cancer cells and its modulation by erythromycin
|
Chen, Shu-zhen
|
|
2005
|
56 |
2 |
p. 212-220
|
article
|
| 6 |
Human cells deficient in transcription-coupled repair show prolonged activation of the Jun N-terminal kinase and increased sensitivity following cisplatin treatment
|
Bulmer, J. Todd
|
|
2005
|
56 |
2 |
p. 189-198
|
article
|
| 7 |
Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin
|
Barthomeuf, Chantal
|
|
2005
|
56 |
2 |
p. 173-181
|
article
|
| 8 |
In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative
|
Hollingshead, Melinda
|
|
2005
|
56 |
2 |
p. 115-125
|
article
|
| 9 |
Pharmacokinetic and pharmacodynamic comparison of fluoropyrimidine derivatives, capecitabine and 5′-deoxy-5-fluorouridine (5′-DFUR)
|
Ebi, Hiromichi
|
|
2005
|
56 |
2 |
p. 205-211
|
article
|
| 10 |
Phase-I dose escalation and sequencing study of docetaxel and continuous infusion topotecan in patients with advanced malignancies
|
Posey, James A.
|
|
2005
|
56 |
2 |
p. 182-188
|
article
|
| 11 |
Phase I study of the multidrug resistance inhibitor zosuquidar administered in combination with vinorelbine in patients with advanced solid tumours
|
Lê, Lyly H.
|
|
2005
|
56 |
2 |
p. 154-160
|
article
|
| 12 |
Preclinical pharmacokinetics and oral bioavailability of BMS-310705, a novel epothilone B analog
|
Kamath, Amrita V.
|
|
2005
|
56 |
2 |
p. 145-153
|
article
|
| 13 |
Single nucleotide polymorphisms modify the transporter activity of ABCG2
|
Morisaki, Kuniaki
|
|
2005
|
56 |
2 |
p. 161-172
|
article
|
Journal description